MiMedx Group, Inc. (MDXG) stock
MDXGNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 12/3040% below fair value
$3.18+0.00 (0.00%)
Close on Nov 18, 2026Market cap $464.04MP/E –Yield –
MiMedx operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
MiMedx's operating cash flow for the twelve months ending Sep 30, 2026 was $20.74M, down 69.4% year over year. For fiscal 2025 it was $74.00M, up 11.8% from the year before. Over ten years it grew 14.7% a year on average. The highest annual figure on record is $74.00M in fiscal 2025.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $74.00M | +11.8% |
| FY2024 | Dec 31, 2024 | $66.20M | +147.2% |
| FY2023 | Dec 31, 2023 | $26.78M | – |
| FY2022 | Dec 31, 2022 | -$17.89M | – |
| FY2021 | Dec 31, 2021 | -$1.98M | – |
| FY2020 | Dec 31, 2020 | -$30.26M | – |
| FY2019 | Dec 31, 2019 | -$39.41M | -210.1% |
| FY2018 | Dec 31, 2018 | $35.80M | -43.1% |
| FY2017 | Dec 31, 2017 | $62.94M | +163.9% |
| FY2016 | Dec 31, 2016 | $23.85M | +26.8% |
| FY2015 | Dec 31, 2015 | $18.81M | +11.9% |
| FY2014 | Dec 31, 2014 | $16.80M | – |
| FY2013 | Dec 31, 2013 | -$284.00K | – |
| FY2012 | Dec 31, 2012 | -$3.33M | – |
| FY2011 | Dec 31, 2011 | -$6.66M | – |
| FY2010 | Dec 31, 2010 | -$8.16M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $3.92M | -86.6% |
| Q2 FY2026 | Jun 30, 2026 | -$10.02M | -169.5% |
| Q1 FY2026 | Mar 31, 2026 | $1.88M | -64.5% |
| Q4 FY2025 | Dec 31, 2025 | $24.96M | +32.9% |
| Q3 FY2025 | Sep 30, 2025 | $29.33M | +49.5% |
| Q2 FY2025 | Jun 30, 2025 | $14.42M | -33.9% |
| Q1 FY2025 | Mar 31, 2025 | $5.30M | -11.4% |
| Q4 FY2024 | Dec 31, 2024 | $18.78M | +83.1% |
| Q3 FY2024 | Sep 30, 2024 | $19.62M | +53.4% |
| Q2 FY2024 | Jun 30, 2024 | $21.81M | +180.6% |
| Q1 FY2024 | Mar 31, 2024 | $5.98M | – |
| Q4 FY2023 | Dec 31, 2023 | $10.26M | – |
| Q3 FY2023 | Sep 30, 2023 | $12.79M | +1233.8% |
| Q2 FY2023 | Jun 30, 2023 | $7.78M | – |
| Q1 FY2023 | Mar 31, 2023 | -$4.05M | – |
| Q4 FY2022 | Dec 31, 2022 | -$5.62M | – |
| Q3 FY2022 | Sep 30, 2022 | $959.00K | -84.8% |
| Q2 FY2022 | Jun 30, 2022 | -$3.01M | -287.9% |
| Q1 FY2022 | Mar 31, 2022 | -$10.22M | – |
| Q4 FY2021 | Dec 31, 2021 | -$3.23M | – |
| Q3 FY2021 | Sep 30, 2021 | $6.33M | – |
| Q2 FY2021 | Jun 30, 2021 | $1.60M | – |
| Q1 FY2021 | Mar 31, 2021 | -$6.68M | – |
| Q4 FY2020 | Dec 31, 2020 | -$10.27M | – |
| Q3 FY2020 | Sep 30, 2020 | -$4.62M | – |
| Q2 FY2020 | Jun 30, 2020 | -$3.10M | -245.4% |
| Q1 FY2020 | Mar 31, 2020 | -$12.28M | – |
| Q4 FY2019 | Dec 31, 2019 | -$23.12M | -1607.3% |
| Q3 FY2019 | Sep 30, 2019 | -$3.16M | -193.0% |
| Q2 FY2019 | Jun 30, 2019 | $2.13M | -89.7% |
| Q1 FY2019 | Mar 31, 2019 | -$15.26M | -250.0% |
| Q4 FY2018 | Dec 31, 2018 | $1.53M | -92.6% |
| Q3 FY2018 | Sep 30, 2018 | $3.40M | -81.1% |
| Q2 FY2018 | Jun 30, 2018 | $20.69M | +53.4% |
| Q1 FY2018 | Mar 31, 2018 | $10.18M | -4.4% |
| Q4 FY2017 | Dec 31, 2017 | $20.87M | +41.9% |
| Q3 FY2017 | Sep 30, 2017 | $17.95M | – |
| Q2 FY2017 | Jun 30, 2017 | $13.48M | – |
| Q1 FY2017 | Mar 31, 2017 | $10.64M | – |
| Q4 FY2016 | Dec 31, 2016 | $14.70M | – |
See a number that looks wrong?